Genetic and family studies have indicated that Graves disease and Hashimoto thyroiditis have a heritable component which appears to be shared to some extend also with some other autoimmune diseases (AIDs). In the present nation-wide study we describe familial risk for Graves disease and Hashimoto thyroiditis identified from the Swedish Hospital Discharge Register (years 1964 through 2012) and the Outpatient Register (2001 through 2012). Family relationships were obtained from the Multigeneration Register and cancers from the Cancer Registry. Familial standardized incidence ratios (SIRs) were calculated for 29,005 offspring with Graves disease and for 25,607 offspring with Hashimoto thyroiditis depending on any of 43 AIDs in parents or siblings. The concordant familial risks for Graves disease and Hashimoto thyroiditis were 3.85 and 4.75, higher for men than for women. The familial risks were very high (11.35, Graves and 22.06, Hashimoto) when both a parent and a sibling were affected. Spousal familial risks were higher for Hashimoto thyroiditis (1.98/1.93) than for Graves disease (1.48/1.50). For Graves disease, 24 discordant AIDs showed a significant association; for Hashimoto thyroiditis, 20 discordant associations were significant. All significant discordant associations were positive for the two thyroid AIDs, with the exception of Hashimoto thyroiditis with Reiter disease. Overall 8 associations were significant only for Graves disease and 6 Hashimoto thyroiditis. The overall high concordant familial risks for Graves disease and Hashimoto thyroiditis suggest a strong genetic contribution to the familial risk. Significant familial associations among more than half of the 43 AIDs attest to the extensive polyautoimmunity among thyroid AIDs.

Center for Primary Health Care Research Lund University Malmö Sweden

Division of Cancer Epidemiology German Cancer Research Centre 69120 Heidelberg Germany

Division of Molecular Genetic Epidemiology German Cancer Research Centre 69120 Heidelberg Germany

Division of Pediatric Neurooncology German Cancer Research Center Heidelberg Germany

Faculty of Medicine and Biomedical Center in Pilsen Charles University Prague 30605 Pilsen Czech Republic

GeneWerk GmbH 69120 Heidelberg Germany

Hopp Children's Cancer Center Heidelberg Germany

Stanford Prevention Research Center Stanford University School of Medicine Stanford CA 94305 5705 USA

Zobrazit více v PubMed

Bliddal S., Nielsen C.H., Feldt-Rasmussen U. Recent advances in understanding autoimmune thyroid disease: the tallest tree in the forest of polyautoimmunity. F1000Res. 2017;6:1776. PubMed PMC

Antonelli A., Fallahi P., Elia G., Ragusa F., Paparo S.R., Ruffilli I. Graves’ disease: clinical manifestations, immune pathogenesis (cytokines and chemokines) and therapy. Best Pract. Res. Clin. Endocrinol. Metabol. 2020:101388. PubMed

Ragusa F., Fallahi P., Elia G., Gonnella D., Paparo S.R., Giusti C. Hashimotos’ thyroiditis: epidemiology, pathogenesis, clinic and therapy. Best Pract. Res. Clin. Endocrinol. Metabol. 2019:101367. PubMed

Fallahi P., Elia G., Ragusa F., Ruffilli I., Camastra S., Giusti C. The aggregation between AITD with rheumatologic, or dermatologic, autoimmune diseases. Best Pract. Res. Clin. Endocrinol. Metabol. 2019:101372. PubMed

Shukla S.K., Singh G., Ahmad S., Pant P. Infections, genetic and environmental factors in pathogenesis of autoimmune thyroid diseases. Microb. Pathog. 2018;116:279–288. PubMed

Luty J., Ruckemann-Dziurdzinska K., Witkowski J.M., Bryl E. Immunological aspects of autoimmune thyroid disease - complex interplay between cells and cytokines. Cytokine. 2019;116:128–133. PubMed

Dougan M., Pietropaolo M. Time to dissect the autoimmune etiology of cancer antibody immunotherapy. J. Clin. Invest. 2020;130:51–61. PubMed PMC

Hwangbo Y., Park Y.J. Genome-wide association studies of autoimmune thyroid diseases, thyroid function, and thyroid cancer. Endocrinol. Metab. (Seoul) 2018;33:175–184. PubMed PMC

Vejrazkova D., Vcelak J., Vaclavikova E., Vankova M., Zajickova K., Duskova M. Genetic predictors of the development and recurrence of Graves’ disease. Physiol. Res. 2018;67 S431-s9. PubMed

Hemminki K., Li X., Sundquist J., Sundquist K. The epidemiology of Graves’ disease: evidence of a genetic and an environmental contribution. J. Autoimmun. 2010;34:J307–J313. PubMed

Dittmar M., Libich C., Brenzel T., Kahaly G.J. Increased familial clustering of autoimmune thyroid diseases. Hormone Metab. Res. = Hormon- und Stoffwechselforschung = Hormones et metabolisme. 2011;43:200–204. PubMed

Hemminki K., Forsti A., Sundquist K., Sundquist J., Li X. Familial associations of monoclonal gammopathy of unknown significance with autoimmune diseases. Leukemia. 2016;30:1766–1769. PubMed

Hemminki K., Ji J., Brandt A., Mousavi S.M., Sundquist J. The Swedish Family-Cancer Database 2009: prospects for histology-specific and immigrant studies. Int. J. Canc. 2010;126:2259–2267. PubMed

Abraham-Nordling M., Byström K., Törring O., Lantz M., Berg G., Calissendorff J. Incidence of hyperthyroidism in Sweden. Eur. J. Endocrinol. 2011;165:899–905. PubMed

Ludvigsson J.F., Andersson E., Ekbom A., Feychting M., Kim J.L., Reuterwall C. External review and validation of the Swedish national inpatient register. BMC Publ. Health. 2011;11:450. PubMed PMC

Carter C. The inheritance of congenital pyloric stenosis. Br. Med. Bull. 1961;17:251–254. PubMed

Vogel F., Motulsky A. Springer; Heidelberg: 1996. Human Genetics: Problems and Approaches.

Frank C., Fallah M., Sundquist J., Hemminki A., Hemminki K. Population landscape of familial cancer. Sci. Rep. 2015;5:12891. PubMed PMC

Hemminki K., Li X., Sundquist K., Sundquist J. Familial risks for common diseases: etiologic clues and guidance to gene identification Mutat. Res. Rev. 2008;658:247–258. PubMed

Weires M., Bermejo J.L., Sundquist J., Hemminki K. Clustering of concordant and discordant cancer types in Swedish couples is rare. Eur. J. Canc. 2011;47:98–106. PubMed

Cho J.H., Gregersen P.K. Genomics and the multifactorial nature of human autoimmune disease. N. Engl. J. Med. 2011;365:1612–1623. PubMed

Ramos P.S., Criswell L.A., Moser K.L., Comeau M.E., Williams A.H., Pajewski N.M. A comprehensive analysis of shared loci between systemic lupus erythematosus (SLE) and sixteen autoimmune diseases reveals limited genetic overlap. PLoS Genet. 2011;7 PubMed PMC

Li Y.R., Li J., Zhao S.D., Bradfield J.P., Mentch F.D., Maggadottir S.M. Meta-analysis of shared genetic architecture across ten pediatric autoimmune diseases. Nat. Med. 2015;21:1018–1027. PubMed PMC

Tajuddin S.M., Schick U.M., Eicher J.D., Chami N., Giri A., Brody J.A. Large-scale exome-wide association analysis identifies loci for white blood cell traits and pleiotropy with immune-mediated diseases. Am. J. Hum. Genet. 2016;99:22–39. PubMed PMC

Law P.J., Sud A., Mitchell J.S., Henrion M., Orlando G., Lenive O. Genome-wide association analysis of chronic lymphocytic leukaemia, Hodgkin lymphoma and multiple myeloma identifies pleiotropic risk loci. Sci. Rep. 2017;7:41071. PubMed PMC

Wu I.B., Schwartz R.A. Reiter’s syndrome: the classic triad and more. J. Am. Acad. Dermatol. 2008;59:113–121. PubMed

Brent G.A. Environmental exposures and autoimmune thyroid disease. Thyroid. 2010;20:755–761. PubMed PMC

Population-Attributable Fractions of Personal Comorbidities for Liver, Gallbladder, and Bile Duct Cancers

Second Primary Cancers After Liver, Gallbladder and Bile Duct Cancers, and These Cancers as Second Primary Cancers

Familial Risks between Pernicious Anemia and Other Autoimmune Diseases in the Population of Sweden

Familial risks between giant cell arteritis and Takayasu arteritis and other autoimmune diseases in the population of Sweden